These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35074934)

  • 1. Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges.
    Nezam D; Porcher R; Grolleau F; Morel P; Titeca-Beauport D; Faguer S; Karras A; Solignac J; Jourde-Chiche N; Maurier F; Sakhi H; El Karoui K; Mesbah R; Carron PL; Audard V; Ducloux D; Paule R; Augusto JF; Aniort J; Tiple A; Rafat C; Beaudreuil S; Puéchal X; Gobert P; Massy Z; Hanrotel C; Bally S; Martis N; Durel CA; Desbuissons G; Godmer P; Hummel A; Perrin F; Néel A; De Moreuil C; Goulenok T; Guerrot D; Grange S; Foucher A; Deroux A; Cordonnier C; Guilbeau-Frugier C; Modesto-Segonds A; Nochy D; Daniel L; Moktefi A; Rabant M; Guillevin L; Régent A; Terrier B;
    J Am Soc Nephrol; 2022 Mar; 33(3):628-637. PubMed ID: 35074934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of histopathological findings for predictive scoring of short-term treatment response to plasma exchange in severe ANCA-associated renal vasculitides.
    Hakroush S; Korsten P; Ströbel P; Tampe B
    Front Immunol; 2024; 15():1340999. PubMed ID: 38380320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?
    Toyoda T; Yates M; Watts RA
    Curr Rheumatol Rep; 2022 Apr; 24(4):111-117. PubMed ID: 35316496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group.
    de Luna G; Chauveau D; Aniort J; Carron PL; Gobert P; Karras A; Marchand-Adam S; Maurier F; Hatron PY; Mania A; le Guenno G; Bally S; Bienvenu B; Cardineau E; Goulenok T; Jourde-Chiche N; Samson M; Huart A; Pourrat J; Tiple A; Aumaitre O; Puéchal X; Heshmati F; le Jeunne C; Mouthon L; Guillevin L; Terrier B;
    J Autoimmun; 2015 Dec; 65():49-55. PubMed ID: 26330347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
    Casal Moura M; Irazabal MV; Eirin A; Zand L; Sethi S; Borah BJ; Winters JL; Moriarty JP; Cartin-Ceba R; Berti A; Baqir M; Thompson GE; Makol A; Warrington KJ; Thao V; Specks U; Fervenza FC
    J Am Soc Nephrol; 2020 Nov; 31(11):2688-2704. PubMed ID: 32826324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS).
    Fussner LA; Flores-Suárez LF; Cartin-Ceba R; Specks U; Cox PG; Jayne DRW; Merkel PA; Walsh M;
    Am J Respir Crit Care Med; 2024 May; 209(9):1141-1151. PubMed ID: 38346237
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
    Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
    Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis.
    Bellos I; Michelakis I; Nikolopoulos D
    Clin Rheumatol; 2021 Apr; 40(4):1447-1456. PubMed ID: 32935248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implication of plasma exchange on life-threatening antineutrophil cytoplasmic antibody-associated vasculitis.
    Park PG; Yoo BW; Song JJ; Park YB; Lee SW
    BMC Pulm Med; 2020 May; 20(1):147. PubMed ID: 32466756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
    Özçelik G; Sönmez HE; Şahin S; Özağarı A; Bayram MT; Çiçek RY; Çakıcı EK; Çomak E; Barut K; Şahin N; Bakkaloğlu S; Gökçe İ; Düzova A; Bilginer Y; Açarı C; Melek E; Kılıç BD; Özdel S; Adroviç A; Kasapçopur Ö; Ünsal E; Alpay H; Orhan D; Topaloğlu R; Düşünsel R; Özen S
    Pediatr Nephrol; 2019 May; 34(5):847-854. PubMed ID: 30607566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange for the management of ANCA-associated vasculitis: the con position.
    Specks U; Fussner LA; Cartin-Ceba R; Casal Moura M; Zand L; Fervenza FC
    Nephrol Dial Transplant; 2021 Jan; 36(2):231-236. PubMed ID: 33374017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney Histopathology in ANCA-Associated Vasculitides Treated with Plasma Exchange.
    Casal Moura M; Soler MJ; Sethi S; Fervenza FC; Specks U
    J Am Soc Nephrol; 2022 Jun; 33(6):1223-1224. PubMed ID: 35410878
    [No Abstract]   [Full Text] [Related]  

  • 13. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
    Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
    Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange in ANCA-associated vasculitis: the pro position.
    Kronbichler A; Shin JI; Wang CS; Szpirt WM; Segelmark M; Tesar V
    Nephrol Dial Transplant; 2021 Jan; 36(2):227-231. PubMed ID: 33374018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.
    Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR;
    Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic effect of plasma exchange on ANCA-associated vasculitis: A meta-analysis.
    Zhu Y; Rao J; Liu L; Ou J; Li W; Xue C
    Clin Nephrol; 2021 Jun; 95(6):312-322. PubMed ID: 33749583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exchange in patients with ANCA-associated vasculitis.
    Chalkia A; Petras D
    Transfus Apher Sci; 2024 Feb; 63(1):103847. PubMed ID: 38008685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between histopathological classification and renal outcome, ANCA subtype and treatment regimens in ANCA-associated vasculitis.
    Kristensen T; Gregersen JW; Krag SR; Ivarsen P
    Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S105-10. PubMed ID: 27241586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and late effects of therapeutic plasma exchange in patients with systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis: A single-center experience.
    Al Hamzi HA; Al-Mayouf SM; Al Shaikh AA; Al-Sheikh HA; Alshomar AA; Al Humaidan HA; Al Dalaan AN; Al Saleh SS
    Saudi J Kidney Dis Transpl; 2019; 30(4):775-780. PubMed ID: 31464233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis--a 25-year perspective.
    Szpirt WM
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i146-9. PubMed ID: 25770166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.